TABLE 2. Receipt of prenatal care among birth parents of infants with congenital syphilis, by prenatal syphilis testing and treatment among those with timely testing* — United States, 2022.
| Prenatal testing and treatment | Prenatal care, no. (%) |
|
|---|---|---|
| None documented | One or more prenatal care visit | |
|
Testing
| ||
| No test or nontimely test |
969 (70.0) |
416 (30.0) |
| Late identification of seroconversion† |
12 (6.1) |
185 (93.9) |
| Timely test* during pregnancy |
445 (20.4) |
1,734 (79.6) |
|
Total
|
1,426 (37.9)
|
2,335 (62.1)
|
|
Treatment among persons who received timely testing
| ||
| No treatment |
69 (16.3) |
354 (83.7) |
| Inadequate treatment |
362 (24.2) |
1,132 (75.8) |
| Adequate treatment§ |
14 (5.3) |
248 (94.7) |
| Total | 445 (20.4) | 1,734 (79.6) |
* Timely testing is performed ≥30 days before delivery.
† A new reactive syphilis test <30 days before delivery after a nonreactive test earlier in pregnancy.
§ Receipt of a penicillin-based regimen, dosed and spaced appropriately for the stage of syphilis, and commenced ≥30 days before delivery.